Stock Analysis on Net

Monsanto Co. (NYSE:MON)

$22.49

This company has been moved to the archive! The financial data has not been updated since April 5, 2018.

Economic Value Added (EVA)

Microsoft Excel

EVA is registered trademark of Stern Stewart.

Economic value added or economic profit is the difference between revenues and costs,where costs include not only expenses, but also cost of capital.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Economic Profit

Monsanto Co., economic profit calculation

US$ in millions

Microsoft Excel
12 months ended: Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014 Aug 31, 2013 Aug 31, 2012
Net operating profit after taxes (NOPAT)1
Cost of capital2
Invested capital3
 
Economic profit4

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

1 NOPAT. See details »

2 Cost of capital. See details »

3 Invested capital. See details »

4 2017 Calculation
Economic profit = NOPAT – Cost of capital × Invested capital
= × =


Analysis of the economic profit indicates a consistent inability to generate returns exceeding the cost of capital over the six-year period from 2012 to 2017. Economic profit remained negative throughout the entire duration, signifying that the company failed to create economic value for its shareholders, as the net operating profit after taxes (NOPAT) was insufficient to cover the imputed cost of the invested capital.

Net Operating Profit After Taxes (NOPAT) Trends
NOPAT exhibited significant volatility, peaking at 2,743 million US dollars in 2013 before entering a general decline that reached a low of 1,816 million US dollars in 2016. A recovery occurred in 2017, with NOPAT rising to 2,582 million US dollars. This instability in operational profitability contributed to the fluctuating levels of economic loss.
Cost of Capital Dynamics
The cost of capital showed a downward trend for the first four years, decreasing from a high of 18.75% in 2013 to 16.39% in 2015. This reduction suggests a lower required rate of return or a decrease in the perceived risk profile during that interval. However, the cost of capital began to rise again in 2016 and 2017, ending the period at 17.08%.
Invested Capital Fluctuations
Invested capital grew steadily from 14,553 million US dollars in 2012 to a peak of 18,327 million US dollars in 2015. A sharp contraction followed in 2016, where invested capital dropped to 15,963 million US dollars, before slightly increasing to 16,366 million US dollars in 2017. The expansion of the capital base up to 2015, without a corresponding increase in NOPAT, amplified the economic losses during that period.
Economic Profit Performance
Economic profit remained negative throughout the observation period, with the most severe value destruction occurring in 2016, when the loss reached 807 million US dollars. The depth of the economic loss in 2015 and 2016 is attributable to the combination of peak invested capital and declining NOPAT. While economic profit improved to -213 million US dollars by 2017, the company remained unable to reach a break-even point where operating profits exceed the cost of capital.

Net Operating Profit after Taxes (NOPAT)

Monsanto Co., NOPAT calculation

US$ in millions

Microsoft Excel
12 months ended: Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014 Aug 31, 2013 Aug 31, 2012
Net income attributable to Monsanto Company
Deferred income tax expense (benefit)1
Increase (decrease) in allowance for doubtful trade receivables2
Increase (decrease) in LIFO reserve3
Increase (decrease) in deferred revenues4
Increase (decrease) in restructuring reserves5
Increase (decrease) in equity equivalents6
Interest expense
Interest expense, operating lease liability7
Adjusted interest expense
Tax benefit of interest expense8
Adjusted interest expense, after taxes9
(Gain) loss on marketable securities
Interest income
Investment income, before taxes
Tax expense (benefit) of investment income10
Investment income, after taxes11
(Income) loss from discontinued operations, net of tax12
Net income (loss) attributable to noncontrolling interest
Net operating profit after taxes (NOPAT)

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

1 Elimination of deferred tax expense. See details »

2 Addition of increase (decrease) in allowance for doubtful trade receivables.

3 Addition of increase (decrease) in LIFO reserve. See details »

4 Addition of increase (decrease) in deferred revenues.

5 Addition of increase (decrease) in restructuring reserves.

6 Addition of increase (decrease) in equity equivalents to net income attributable to Monsanto Company.

7 2017 Calculation
Interest expense on capitalized operating leases = Operating lease liability × Discount rate
= × =

8 2017 Calculation
Tax benefit of interest expense = Adjusted interest expense × Statutory income tax rate
= × 35.00% =

9 Addition of after taxes interest expense to net income attributable to Monsanto Company.

10 2017 Calculation
Tax expense (benefit) of investment income = Investment income, before tax × Statutory income tax rate
= × 35.00% =

11 Elimination of after taxes investment income.

12 Elimination of discontinued operations.


The financial data reveals certain trends in profitability for the analyzed company over a six-year period ending August 31, 2017.

Net Income Attributable to the Company

Net income shows an overall fluctuating pattern across the years. It increased steadily from 2045 million US dollars in 2012 to a peak of 2740 million in 2014. Subsequently, it experienced a decline to 2314 million in 2015 and a more pronounced decrease to 1336 million in 2016, indicating a significant setback in profitability during that year. However, the net income rebounded sharply to 2260 million in 2017, signaling recovery but not reaching the earlier peak levels.

Net Operating Profit After Taxes (NOPAT)

NOPAT similarly experienced variations over the examined period. It rose from 2247 million USD in 2012 to 2743 million in 2013, before slightly declining to 2633 million in 2014. The value then decreased further to 2361 million in 2015 and took a more substantial fall to 1816 million in 2016. In 2017, NOPAT saw a notable recovery to 2582 million. This suggests operational efficiency or profitability challenges during 2015 and 2016 with improvement thereafter.

Overall, both net income and NOPAT indicate a peak generally around 2013-2014, followed by declines in 2015 and notably in 2016. The recovery in 2017 reflects a positive turnaround. The inconsistency observed in both metrics suggests volatility in profitability and operational performance during these years, highlighting a period of financial challenges mid-cycle with subsequent recovery efforts yielding results by the final year reported.


Cash Operating Taxes

Monsanto Co., cash operating taxes calculation

US$ in millions

Microsoft Excel
12 months ended: Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014 Aug 31, 2013 Aug 31, 2012
Income tax provision from continuing operations
Less: Deferred income tax expense (benefit)
Add: Tax savings from interest expense
Less: Tax imposed on investment income
Cash operating taxes

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).


Income Tax Provision from Continuing Operations
The income tax provision from continuing operations exhibited a fluctuating trend over the six-year period. Starting at 901 million USD in 2012, a slight increase to 915 million USD was observed in 2013. This upward movement continued more notably in 2014, reaching a peak of 1,078 million USD. However, the subsequent years showed a declining pattern: it decreased to 864 million USD in 2015, further dropped to 695 million USD in 2016, and reached its lowest point at 626 million USD in 2017. Overall, despite an initial rise until 2014, the income tax provision has generally declined in the latter part of the timeframe.
Cash Operating Taxes
Cash operating taxes demonstrated more volatility relative to the income tax provision. Beginning at 708 million USD in 2012, there was a steady increase to 821 million USD in 2013, followed by a substantial spike to 1,179 million USD in 2014. The upward trend continued into 2015, peaking at 1,272 million USD. However, unlike income tax provision, cash operating taxes experienced a sharp decrease in 2016, falling to 801 million USD, and then a further decline to 719 million USD by 2017. Despite the fluctuations, the values at the end of the period remained higher than the initial 2012 figures.
Comparative Observations
Both income tax provision and cash operating taxes display a pattern of increasing values through the early years, reaching peaks around 2014 or 2015, followed by a notable decline in the last two years. The cash operating taxes showed more pronounced increases and decreases compared to the income tax provision, suggesting greater variability in actual tax cash outflows relative to the accounting provisions. The consistent decline in both items after 2015 might indicate changes in tax strategy, operational performance, or tax regulations affecting the company's tax liabilities.

Invested Capital

Monsanto Co., invested capital calculation (financing approach)

US$ in millions

Microsoft Excel
Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014 Aug 31, 2013 Aug 31, 2012
Short-term debt, including current portion of long-term debt
Long-term debt, excluding current portion
Operating lease liability1
Total reported debt & leases
Total Monsanto Company shareowners’ equity
Net deferred tax (assets) liabilities2
Allowance for doubtful trade receivables3
Excess of FIFO over LIFO cost4
Deferred revenues5
Restructuring reserves6
Equity equivalents7
Accumulated other comprehensive (income) loss, net of tax8
Noncontrolling interest
Adjusted total Monsanto Company shareowners’ equity
Construction in progress and other9
Investments10
Invested capital

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

1 Addition of capitalized operating leases.

2 Elimination of deferred taxes from assets and liabilities. See details »

3 Addition of allowance for doubtful accounts receivable.

4 Addition of LIFO reserve. See details »

5 Addition of deferred revenues.

6 Addition of restructuring reserves.

7 Addition of equity equivalents to total Monsanto Company shareowners’ equity.

8 Removal of accumulated other comprehensive income.

9 Subtraction of construction in progress and other.

10 Subtraction of investments.


The financial data reveals several important trends and shifts over the six-year period ending August 31, 2017.

Total reported debt & leases
This metric shows a notable increase from 2012 through 2015, rising sharply from approximately $2.4 billion to $9.5 billion. The peak occurs in 2015 with a slight decline thereafter, dropping to $8.6 billion by 2017. This suggests a significant increase in leverage or borrowing activities during the mid-period, followed by some reduction in debt levels.
Total Monsanto Company shareowners’ equity
Shareowners’ equity exhibits a declining trend over the years. Starting at about $11.8 billion in 2012, equity increases slightly in 2013 but then declines steadily to a low of $4.5 billion in 2016. A partial recovery to $6.4 billion in 2017 is observed. This decreasing equity position alongside rising debt levels in the earlier years indicates possible financial restructuring or share buybacks impacting the equity base.
Invested capital
Invested capital shows a general upward trend from 2012 through 2015, rising from approximately $14.6 billion to $18.3 billion before declining to around $16.0 billion in 2016. A slight increase to $16.4 billion in 2017 occurs. The growth in invested capital up to 2015 parallels the increases in both debt and equity during that period, suggesting expansion or acquisition initiatives. The subsequent decrease and stabilization may reflect a period of consolidation or reevaluation of capital investment.

Overall, the data suggest that the company experienced increased leverage with a peak in debt around 2015, accompanied by declining shareholders’ equity after 2013. Despite fluctuations, invested capital remained relatively high, implying continued commitment to the company's operational base or growth efforts. The partial recovery in equity and reduction in debt post-2015 could indicate a strategic shift towards strengthening the balance sheet and deleveraging.


Cost of Capital

Monsanto Co., cost of capital calculations

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Debt3 ÷ = × × (1 – 35.00%) =
Operating lease liability4 ÷ = × × (1 – 35.00%) =
Total:

Based on: 10-K (reporting date: 2017-08-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Debt3 ÷ = × × (1 – 35.00%) =
Operating lease liability4 ÷ = × × (1 – 35.00%) =
Total:

Based on: 10-K (reporting date: 2016-08-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Debt3 ÷ = × × (1 – 35.00%) =
Operating lease liability4 ÷ = × × (1 – 35.00%) =
Total:

Based on: 10-K (reporting date: 2015-08-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Debt3 ÷ = × × (1 – 35.00%) =
Operating lease liability4 ÷ = × × (1 – 35.00%) =
Total:

Based on: 10-K (reporting date: 2014-08-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Debt3 ÷ = × × (1 – 35.00%) =
Operating lease liability4 ÷ = × × (1 – 35.00%) =
Total:

Based on: 10-K (reporting date: 2013-08-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Debt3 ÷ = × × (1 – 35.00%) =
Operating lease liability4 ÷ = × × (1 – 35.00%) =
Total:

Based on: 10-K (reporting date: 2012-08-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »


Economic Spread Ratio

Monsanto Co., economic spread ratio calculation, comparison to benchmarks

Microsoft Excel
Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014 Aug 31, 2013 Aug 31, 2012
Selected Financial Data (US$ in millions)
Economic profit1
Invested capital2
Performance Ratio
Economic spread ratio3
Benchmarks
Economic Spread Ratio, Competitors4
lululemon athletica inc.
Nike Inc.

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

1 Economic profit. See details »

2 Invested capital. See details »

3 2017 Calculation
Economic spread ratio = 100 × Economic profit ÷ Invested capital
= 100 × ÷ =

4 Click competitor name to see calculations.


Between 2012 and 2017, the organization consistently generated negative economic profit, indicating that the returns on invested capital did not exceed the company's cost of capital. This sustained negative value demonstrates a persistent inability to create economic value over the six-year period, despite fluctuations in the magnitude of the losses.

Economic Profit Trends
A period of marginal improvement is observed between 2012 and 2014, with losses narrowing from 460 million USD to 159 million USD. However, this trend reversed sharply in 2015 and 2016, with economic profit deteriorating to a peak loss of 807 million USD in 2016. A significant recovery occurred in 2017, bringing the loss back to 213 million USD, a level similar to the 2013 performance.
Invested Capital Dynamics
Invested capital showed a steady upward trajectory from 14,553 million USD in 2012 to a peak of 18,327 million USD in 2015. This expansion in the capital base coincided with a deterioration in economic profit, suggesting that the additional capital deployed during this phase did not yield returns sufficient to cover its associated costs. A reduction in invested capital followed in 2016 to 15,963 million USD, before stabilizing at 16,366 million USD in 2017.
Economic Spread Ratio Performance
The economic spread ratio remained negative throughout the entire period, confirming a persistent gap between the return on invested capital and the cost of capital. The ratio improved from -3.16% in 2012 to its strongest point of -0.98% in 2014. A severe contraction followed, reaching a low of -5.06% in 2016, which represents the widest divergence between actual returns and the required return. By 2017, the ratio recovered to -1.30%, signaling a reduction in the economic value destruction relative to the invested capital base.

Economic Profit Margin

Monsanto Co., economic profit margin calculation, comparison to benchmarks

Microsoft Excel
Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014 Aug 31, 2013 Aug 31, 2012
Selected Financial Data (US$ in millions)
Economic profit1
 
Net sales
Add: Increase (decrease) in deferred revenues
Adjusted net sales
Performance Ratio
Economic profit margin2
Benchmarks
Economic Profit Margin, Competitors3
lululemon athletica inc.
Nike Inc.

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

1 Economic profit. See details »

2 2017 Calculation
Economic profit margin = 100 × Economic profit ÷ Adjusted net sales
= 100 × ÷ =

3 Click competitor name to see calculations.


The analysis of economic value added from 2012 to 2017 reveals a consistent failure to generate positive economic profit. Throughout the six-year period, the entity operated with negative economic profit margins, signifying that returns were insufficient to cover the cost of capital employed.

Economic Profit Trajectory
Economic profit exhibited significant volatility. An initial improving trend occurred between 2012 and 2014, with losses narrowing from -460 million to -159 million. This was followed by a sharp deterioration in 2015 and 2016, where losses expanded to -643 million and -807 million, respectively. A recovery was observed in 2017, with losses reducing to -213 million.
Adjusted Net Sales Performance
Revenue patterns mirrored the trends observed in economic profit. Adjusted net sales increased from 13,435 million in 2012 to a peak of 15,685 million in 2014. A subsequent decline occurred through 2016, with sales reaching a period low of 13,688 million, before rebounding to 14,878 million in 2017.
Economic Profit Margin Analysis
The economic profit margin remained negative for the entire duration. The margin improved from -3.42% in 2012 to its most favorable point of -1.01% in 2014. A severe contraction followed, with the margin widening to -4.31% in 2015 and reaching its lowest point of -5.90% in 2016. The margin improved significantly in 2017 to -1.43%, returning to levels comparable to those seen in 2013.

The correlation between adjusted net sales and economic profit suggests that capital efficiency was closely tied to revenue volume. The period from 2015 to 2016 represents a phase of acute economic value destruction, while 2017 indicates a return to previous baseline levels of underperformance relative to the cost of capital.